Microbiology & Infectious Diseases

New research identifies HIV PrEP drugs and MCL-1 inhibitors as promising treatments for HTLV-1c, a neglected virus causing severe disease in Indigenous populations.

A European cohort study finds only 40% of patients with extensively drug-resistant tuberculosis achieved successful treatment outcomes, with mortality and failure rates remaining high.

Taking doxycycline after condomless sex significantly reduced bacterial STIs in men who have sex with men and transgender women.

New data show that one dose of the HPV vaccine in girls aged 9–14 triggers strong, lasting immune responses, comparable to a full three-dose course in adult women.

Cord blood biomarkers may help detect early neonatal sepsis, improving diagnosis and reducing unnecessary antibiotic use in preterm infants.

A major global study confirms that malaria resistance diminishes IPTp-SP’s antimalarial benefits but not its impact on low birthweight, prompting urgent calls for new preventive strategies.

WHO has endorsed injectable lenacapavir as a twice-yearly HIV prevention tool, offering new hope for communities facing high infection risks and adherence barriers.

Outbreak response vaccinations have prevented 5.81 million cases and saved USD 31 billion in LMICs since 2000.